Agree @NZ Trader
I hope the offer is a canine licence agreement or PAA equity injection from a company with deep pockets and who will ensure (demand) PAA's full suite of trials proceed post haste under a new and reinvigorated management team
Ann: Cohort 3 Pharmacokinetics in MND Patients Completed, page-100
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
23.5¢ |
Change
0.030(14.6%) |
Mkt cap ! $93.03M | |||
| Open | High | Low | Value | Volume |
| 23.0¢ | 24.5¢ | 22.5¢ | $917.2K | 3.896M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 6654 | 23.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 23.5¢ | 138829 | 1 |
View Market Depth
| Last trade - 16.10pm 05/06/2024 (20 minute delay) ? |
|
|||||
|
Last
23.0¢ |
Change
0.030 ( 12.2 %) |
||||
| Open | High | Low | Volume | ||
| 24.0¢ | 24.5¢ | 22.5¢ | 1712220 | ||
| Last updated 15.54pm 05/06/2024 ? | |||||
| PAA (ASX) Chart |